Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1799]
News [2695]
Articles [198]
Editorials [1]
Conferences [135]
elearning [13]
Capecitabine monotherapy does not improve survival in elderly patients with...
Prof Gunter von Minckwitz – German Breast Group, Neu-Isenburg, Germany
Capecitabine monotherapy does not improve survival in elderly patients with early-stage breast cancer ( Prof Gunter von Minckwitz – German Breast Group, Neu-Isenburg, Germany )
11 Dec 2014
Impact of adding bevacizumab to presurgery chemo for triple-negative breast...
Dr William Sikov - Women and Infants Hospital, Providence, USA
Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype ( Dr William Sikov - Women and Infants Hospital, Providence, USA )
11 Dec 2014
Capecitabine monotherapy does not improve survival in elderly patients with...
Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany
Capecitabine monotherapy does not improve survival in elderly patients with early-stage breast cancer ( Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany )
11 Dec 2014
Best of ASH 2014
Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert...
Best of ASH 2014 ( Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert Ossenkoppele )
8 Dec 2014
ASH 2014: Highlights in CLL from ASH 2014
Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger
ASH 2014: Highlights in CLL from ASH 2014 ( Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger )
8 Dec 2014
Busulfan exposure dose tested for MDS and AML
Dr Ravi Vij - Washington University School of Medicine, St Louis, USA
Busulfan exposure dose tested for MDS and AML ( Dr Ravi Vij - Washington University School of Medicine, St Louis, USA )
8 Dec 2014
Combination therapy for high-risk MDS? Not quite yet
Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA
Combination therapy for high-risk MDS? Not quite yet ( Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA )
8 Dec 2014
Results of HD2000 trial comparing combination therapies in advanced-stage...
Prof Massimo Federico - University of Modena and Reggio Emilia, Modena, Italy
Results of HD2000 trial comparing combination therapies in advanced-stage Hodgkin's lymphoma ( Prof Massimo Federico - University of Modena and Reggio Emilia, Modena, Italy )
8 Dec 2014
ASH 2014: Highlights in mantle cell lymphoma
Prof Steven Le Gouill and Prof Simon Rule
ASH 2014: Highlights in mantle cell lymphoma ( Prof Steven Le Gouill and Prof Simon Rule )
8 Dec 2014
ASH 2014: Highlights in multiple myeloma
Prof Philippe Moreau, Prof Keith Stewart, Prof Marivi Mateos, Prof Meletios...
ASH 2014: Highlights in multiple myeloma ( Prof Philippe Moreau, Prof Keith Stewart, Prof Marivi Mateos, Prof Meletios Dimopoulos )
8 Dec 2014
Tyrosine kinase inhibitor in combination with chemo shows benefit in acute...
Dr Christoph Röllig - University Hospital Dresden, Dresden, Germany
Tyrosine kinase inhibitor in combination with chemo shows benefit in acute myeloid leukaemia ( Dr Christoph Röllig - University Hospital Dresden, Dresden, Germany )
7 Dec 2014
New cytarabine combinations could overcome toxicities in AML treatment
Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA
New cytarabine combinations could overcome toxicities in AML treatment ( Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA )
7 Dec 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation